Submitted by Anonymous (not verified) on 28 November 2023 - 15:59
Human medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 06/01/2022, Revision: 3, Status: Authorised
Source: